Viewing Study NCT03473002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-03-05 @ 11:19 AM
Study NCT ID: NCT03473002
Status: COMPLETED
Last Update Posted: 2019-03-01
First Post: 2018-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Antiviral Prophylaxis View
None Respiratory Syncytial Virus Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunogenicity View
None Respiratory Syncytial Virus View
None Safety View
None Sendai Virus View
None Vaccine View